NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

全球神經診斷市場:產品、應用、最終用戶、地區(北美、歐洲、亞太地區、拉丁美洲、中東/非洲)趨勢分析、競爭市場份額、預測(2017-2027)

Global Neurodiagnostics Market, By Product, By Application, By End-User, By Region (North America, Europe, Asia-Pacific, Latin America, Middle-East & Africa Trend Analysis, Competitive Market Share & Forecast, 2017-2027

出版商 Blueweave Consulting & Research Private Limited 商品編碼 1023400
出版日期 內容資訊 英文 200 Pages
商品交期: 請詢問到貨日
價格
全球神經診斷市場:產品、應用、最終用戶、地區(北美、歐洲、亞太地區、拉丁美洲、中東/非洲)趨勢分析、競爭市場份額、預測(2017-2027) Global Neurodiagnostics Market, By Product, By Application, By End-User, By Region (North America, Europe, Asia-Pacific, Latin America, Middle-East & Africa Trend Analysis, Competitive Market Share & Forecast, 2017-2027
出版日期: 2021年07月29日內容資訊: 英文 200 Pages
簡介

2020年全球神經診斷市場規模將達到67億美元。預計該市場在預測期內將以 8% 的複合年增長率增長,到 2027 年將達到 114 億美元。預計市場將受到諸如神經系統疾病患病率增加和圖像處理技術進步等因素的推動。

此外,行業公司正在推出各種診斷系統和設備,例如 EMG 設備、CT 掃瞄和 Sanger 測序儀,有望加速市場增長。然而,診斷成像系統的高價會阻礙市場增長,尤其是在新興市場。

本報告調查了全球神經診斷市場,並提供了有關市場增長潛力、未來趨勢、統計數據等方面的信息。它還提供有關市場規模和預測、市場增長因素、挑戰、按產品/應用/最終用戶/地區進行的市場分析、競爭形勢和主要公司概況的信息。

目錄

第 1 章調查框架

第 2 章調查方法

第 3 章執行摘要

第 4 章行業考慮與增長戰略

  • 價值鏈分析
  • DROC 分析
    • 市場增長因素
      • 神經退行性疾□□病患病率增加
      • 神經診斷技術進展
      • 神經影像技術
    • 市場抑制因素
      • 診斷和成像技術成本高
    • 市場挑戰
    • 市場機會
      • Covid-19 大流行正在進行中
      • 增加研發活動
  • 近期趨勢
  • 波特五力分析

第 5 章全球神經診斷市場概述

  • 市場規模和銷售預測(2017-2027)
  • 細分市場規模和預測
    • 按產品
      • 診斷成像系統
      • 臨床診斷設備
      • 試劑和耗材
    • 按應用程序
      • 神經退行性疾□□病
      • 頭痛症
      • 中風
      • 睡眠障礙
      • 癲癇
    • 最終用戶
      • 醫院/手術中心
      • 門診治療
      • 診斷實驗室/影像中心
      • 神經內科中心
      • 學術/研究機構
    • 按地區
      • 北美
      • 歐洲
      • 亞太地區
      • 拉丁美洲
      • 中東和非洲

第 6 章北美神經診斷市場概述

  • 市場規模和預測
    • 按銷售額 (2020-2027)
  • 市場份額及預測
    • 按產品
    • 按應用程序
    • 最終用戶
    • 按國家/地區
      • 美國
      • 加拿大

第 7 章歐洲神經診斷市場概述

  • 市場規模和預測
    • 按銷售額 (2020-2027)
  • 市場份額及預測
    • 按產品
    • 按應用
    • 最終用戶
    • 按國家/地區
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲

第 8 章亞太神經診斷市場概述

  • 市場規模和預測
    • 按銷售額 (2020-2027)
  • 市場份額及預測
    • 按產品
    • 按應用程序
    • 最終用戶
    • 按國家/地區
      • 中國
      • 印度
      • 日本
      • 韓國
      • 亞太地區的其他國家

第 9 章拉丁美洲神經診斷市場概述

  • 市場規模和預測
    • 按銷售額 (2020-2027)
  • 市場份額及預測
    • 按產品
    • 按應用
    • 最終用戶
    • 按國家/地區
      • 墨西哥
      • 巴西
      • 其他

第 10 章中東/非洲神經診斷市場概述

  • 市場規模和預測
    • 按銷售額 (2020-2027)
  • 市場份額及預測
  • 按產品
  • 按應用程序
  • 最終用戶
  • 按國家/地區
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 南非
    • 其他歐洲

第 11 章競爭形勢

  • 主要公司和提供的產品列表
  • 市場份額分析(2020 年)
  • 通過參數操作進行競爭基準測試

第 12 章 COVID-19 對全球神經診斷市場的影響

第 13 章公司概況概述(公司概況、財務矩陣、主要產品情況、主要高管、主要競爭對手、聯繫人和戰略視角)

  • Nihon Kohden Corporation
  • GE Healthcare
  • Canon Medical Systems Corporation
  • Advanced Brain Monitoring, Inc
  • FUJIFILM Holdings Corporation
  • Siemens Healthineers
  • Hoffman-La Roche AG
  • Lifelines Neuro Company
  • Bio-Rad Laboratories
  • Koninklijke Philips N.V.
  • QIAGEN N.V.
  • Natus Medical Incorporated
  • Fujirebio
  • Thermo Fisher Scientific, Inc
  • Agilent Technologies
  • Hitachi, Ltd
  • Ridge Diagnostics
  • Bruker
  • Other Prominent Players

第 14 章主要戰略建議

第 15 章圖列表

目錄
Product Code: BWC2105

Global Neurodiagnostics Market Portrays a Positive Growth: Projected to Grow at a CAGR of 8.0% in the Forecast Period

A recent study conducted by the strategic consulting and market research firm, BlueWeave Consulting, revealed that the global neurodiagnostics market was worth USD 6.7 billion in the year 2020. It is estimated to grow at the CAGR of 8.0%, earning revenue of around USD 11.4 billion by the end of 2027. The global neurodiagnostics market has posted consistent growth over the past few years, and is expected to continue growing throughout the forecast period as well.The market is estimated to gain significant traction because of factors like the increasing prevalence of neurological diseases and technological advancements in imaging technologies. Also, industry players are launching a wide range of diagnostic systems and instruments, such as EMG devices, CT scans, Sanger sequencers, etc., which are expected to drive market growth. However, the high prices of imaging systems may restrict the growth of the global neurodiagnostics market, especially in emerging economies.

Neuroimaging Techniques is Estimated to Drive the Global Neurodiagnostics Market during the Forecast Period

Neuroimaging techniques, generally referred to as brain scans, are widely used to study the structure and function of the brain. The most common types of imaging techniques used are MRI scans, computed tomography (CT) scans, PET scans, MRI scans, functional MRI (fMRI), etc. Imaging techniques such as these are highly effective for detecting and diagnosing cases of psychosis and other illnesses. With the increasing prevalence of neurological disorders, the adoption of neuroimaging techniques has also proliferated, propelling the market growth for the global neurodiagnostics market.

Increasing Research and Development Activities is Estimated to Drive the Market

The existing neurological diagnosis technologies are not very effective when it comes to diagnosing a variety of diseases and disorders. Therefore, experts have realized that there is a need for constant development and evolution of neurodiagnostics technologies. As a result, the diagnostic technologies manufacturers and research institutes are investing significantly towards the study of neurological disorders to gain an in-depth understanding of the conditions to develop effective diagnosis and treatment procedures. The market is therefore expected to be driven by sophisticated neuroimaging techniques, which are being tested in various clinical research trials.

Click here to download free sample report: https://www.blueweaveconsulting.com/global-neurodiagnostics-market/report-sample

Global Neurodiagnostics Market - By End-User

Based on end-users, the global neurodiagnostics market is segmented into hospitals & surgical centers, ambulatory care settings, diagnostic laboratories & imaging centers, neurology centers, and academic & research institutes. The largest share of the market belongs to hospitals and surgical centers due to their large budgets and funding, which enables them to accumulate advanced and expensive medical technologies such as neurodiagnostics devices. Furthermore, the increasing number of hospitals and surgical centers, especially in emerging economies, are also playing a crucial role in propelling the demand for neurodiagnostics equipment in hospitals.

Global Neurodiagnostics Market - Regional Insights

Geographically, the global neurodiagnostics market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle-East & Africa. Among these regions, North America dominated the market. However, the Asia-Pacific region is estimated to witness the highest CAGR during the forecast period. It is believed that one of the key factors that have fueled the neurodiagnostics market's growth in this region is the dispersal of the taboo surrounding neurological diseases. Increasingly, people are getting their mental health issues diagnosed in order to receive early and effective treatment. That is why, countries like India, Japan, South Korea hold a huge potential for market growth in neurodiagnostics.

Impact of COVID-19 on Global Neurodiagnostics Market

The outbreak of the COVID-19 virus negatively impacted the global neurodiagnostics market. The problem was caused by the increasing number of patients affected by COVID-19. Resources were becoming insufficient to handle the situation. The healthcare facilities started investing in respiratory management devices such as ventilators, oxygen supplies, PPE kits, etc. Due to this, the demand for neurodiagnostics systems declined significantly, affecting the market negatively. Additionally, the number of diagnostic tests conducted in healthcare facilities had decreased due to the lockdown, which consequently led to a lower number of hospital visits.

Competitive Landscape

The leading market players in the global neurodiagnosticss market are Nihon Kohden Corporation, GE Healthcare, Canon Medical Systems Corporation, Hoffman-La Roche AG, Advanced Brain Monitoring, Inc, FUJIFILM Holdings Corporation, Siemens Healthineers, Hoffman-La Roche AG, Lifelines Neuro Company, Bio-Rad Laboratories, Koninklijke Philips N.V., QIAGEN N.V., Natus Medical Incorporated, Fujirebio, Thermo Fisher Scientific, Inc, Agilent Technologies, Hitachi, Ltd, Ridge Diagnostics, Bruker, GE Healthcare, and other prominent players.

The market is highly competitive and dense with the presence of several global industry leaders such as Philips, GE Healthcare, FUJIFILM, etc. The companies have been investing significantly in R&D activities and advancements and innovation for product approvals and launches for expanding their portfolio. Furthermore, the adoption of competitive strategies like partnerships, mergers, acquisitions, collaboration is also very prominent in this market.

Don't miss the business opportunity of the global neurodiagnostics market. Consult our analysts to gain crucial insights and facilitate your business growth.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of the global neurodiagnostics market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends of the global neurodiagnostics market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyses the growth drivers, challenges, and competitive dynamics of the market.

About Us

BlueWeave Consulting provides comprehensive Market Intelligence (MI) Solutions to businesses regarding various products and services online and offline. We offer all-inclusive market research reports by analyzing both qualitative and quantitative data to boost up the performance of your business solutions. BWC has built its reputation from the scratch by delivering quality inputs and nourishing long-lasting relationships with its clients. We are one of the promising digital MI solutions companies providing agile assistance to make your business endeavors successful.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Key Market Segments

2. Research Methodology

  • 2.1. Qualitative Research
  • 2.2. Methodology
  • 2.3. Regional Split of Primary & Secondary Research
  • 2.4. Secondary Research
  • 2.5. Primary Research
    • 2.5.1. Breakdown of Primary Research Respondents, By Region
    • 2.5.2. Breakdown of Primary Research Respondents, By Industry Participants
  • 2.6. Market Size Estimation
  • 2.7. Assumptions for the Study
  • 2.8. Market Breakdown & Data Triangulation

3. Executive Summary

4. Industry Insight and Growth Strategy

  • 4.1. Value Chain Analysis
  • 4.2. DROC Analysis
    • 4.2.1. Market Drivers
      • 4.2.1.1. Increasing Prevalence of Neurodegenerative Diseases
      • 4.2.1.2. Technological Advancements in The Neurodiagnostics
      • 4.2.1.3. Neuroimaging Techniques
    • 4.2.2. Market Restraints
      • 4.2.2.1. High Cost of Diagnosis and Imaging Technologies
    • 4.2.3. Market Challenges
      • 4.2.3.1.1. Use of refurbished Products
    • 4.2.4. Market Opportunity
      • 4.2.4.1. The Ongoing Covid-19 Pandemic
      • 4.2.4.2. Increasing Research and Development Activities
  • 4.3. Recent Developments
  • 4.4. Porter's Five Forces Analysis
    • 4.4.1. Bargaining Power of Buyers
    • 4.4.2. Bargaining Power of Suppliers
    • 4.4.3. Intensity of Rivalry
    • 4.4.4. Threat of New Entrants
    • 4.4.5. Threat of Substitutes

5. Global Neurodiagnostics Market Overview

  • 5.1. Market Size & Forecast by Value, 2017-2027
  • 5.2. Market Size and Forecast, By Segment
    • 5.2.1. By Product
      • 5.2.1.1. Diagnostic Imaging Systems
      • 5.2.1.1.1. Ultrasound Imaging Systems
      • 5.2.1.1.2. EEG Systems
      • 5.2.1.1.3. MEG Devices
      • 5.2.1.1.4. MRI Systems
      • 5.2.1.1.5. Angiography Systems
      • 5.2.1.1.6. PET Scanners
      • 5.2.1.1.7. CT Scanners
      • 5.2.1.1.8. EMG Devices
      • 5.2.1.1.9. Other Diagnostic Imaging Systems
      • 5.2.1.2. Clinical Diagnostic Instruments
      • 5.2.1.2.1. PCR Instruments
      • 5.2.1.2.2. NGS Instruments
      • 5.2.1.2.3. Sanger Sequencers
      • 5.2.1.2.4. Other Clinical Diagnostic Instruments
      • 5.2.1.3. Reagents & Consumables
      • 5.2.1.3.1. Media & Sera
      • 5.2.1.3.2. Probes
      • 5.2.1.3.3. Antibodies
      • 5.2.1.3.4. Enzymes, Proteins, & Peptides
      • 5.2.1.3.5. Buffers
      • 5.2.1.3.6. Solvents
      • 5.2.1.3.7. Other Reagents & Consumables
    • 5.2.2. By Application
      • 5.2.2.1. Neurodegenerative Diseases
      • 5.2.2.2. Headache Disorders
      • 5.2.2.3. Stroke
      • 5.2.2.4. Sleep Disorders
      • 5.2.2.5. Epilepsy
    • 5.2.3. By End-user
      • 5.2.3.1. Hospitals & Surgical Centers
      • 5.2.3.2. Ambulatory Care Settings
      • 5.2.3.3. Diagnostic Laboratories & Imaging Centers
      • 5.2.3.4. Neurology Centers
      • 5.2.3.5. Academic & Research Institutes
    • 5.2.4. By Region
      • 5.2.4.1. North America
      • 5.2.4.2. Europe
      • 5.2.4.3. Asia-Pacific
      • 5.2.4.4. Latin America
      • 5.2.4.5. Middle East & Africa

6. North America Neurodiagnostics Market Overview

  • 6.1. Market Size and Forecast
    • 6.1.1. By Value (USD Million), 2020-2027
  • 6.2. Market Share and Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
      • 6.2.4.1. U.S.
      • 6.2.4.2. Canada

7. Europe Neurodiagnostics Market Overview

  • 7.1. Market Size and Forecast
    • 7.1.1. By Value (USD Million), 2020-2027
  • 7.2. Market Share and Forecast
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
      • 7.2.4.1. Germany
      • 7.2.4.2. U.K.
      • 7.2.4.3. France
      • 7.2.4.4. Italy
      • 7.2.4.5. Spain
      • 7.2.4.6. Rest of Europe

8. APAC Neurodiagnostics Market Overview

  • 8.1. Market Size and Forecast
    • 8.1.1. By Value (USD Million), 2020-2027
  • 8.2. Market Share and Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
      • 8.2.4.1. China
      • 8.2.4.2. India
      • 8.2.4.3. Japan
      • 8.2.4.4. South Korea
      • 8.2.4.5. Rest of APAC

9. LATAM Neurodiagnostics Market Overview

  • 9.1. Market Size and Forecast
    • 9.1.1. By Value (USD Million), 2020-2027
  • 9.2. Market Share and Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
      • 9.2.4.1. Mexico
      • 9.2.4.2. Brazil
      • 9.2.4.3. Rest of LATAM

10. MEA Neurodiagnostics Market Overview

  • 10.1. Market Size and Forecast
    • 10.1.1. By Value (USD Million), 2020-2027
  • 10.2. Market Share and Forecast
  • 10.3. By Product
  • 10.4. By Application
  • 10.5. By End User
  • 10.6. By Country
    • 10.6.1. Saudi Arabia
    • 10.6.2. UAE
    • 10.6.3. South Africa
    • 10.6.4. Rest of Europe

11. Competitive Landscape

  • 11.1. List of Key Players and Their Offerings
  • 11.2. Market Share Analysis (2020)
  • 11.3. Competitive Benchmarking, By Operating Parameters

12. Impact of COVID-19 on Global Neurodiagnostics Market

13. Company Profiles (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *

  • 13.1. Nihon Kohden Corporation
  • 13.2. GE Healthcare
  • 13.3. Canon Medical Systems Corporation
  • 13.4. Advanced Brain Monitoring, Inc
  • 13.5. FUJIFILM Holdings Corporation
  • 13.6. Siemens Healthineers
  • 13.7. Hoffman-La Roche AG
  • 13.8. Lifelines Neuro Company
  • 13.9. Bio-Rad Laboratories
  • 13.10. Koninklijke Philips N.V.
  • 13.11. QIAGEN N.V.
  • 13.12. Natus Medical Incorporated
  • 13.13. Fujirebio
  • 13.14. Thermo Fisher Scientific, Inc
  • 13.15. Agilent Technologies
  • 13.16. Hitachi, Ltd
  • 13.17. Ridge Diagnostics
  • 13.18. Bruker
  • 13.19. Other Prominent Players

14. Key Strategic Recommendations

15. List of Figures

  • Fig 1: Global Neurodiagnostics Segmentation
  • Fig 2: Global Neurodiagnostics Market Value Chain Analysis,
  • Fig 3: Company Market Share Analysis, 2020
  • Fig 4: Global Neurodiagnostics Market Size, By Value (USD Million), 2020-2027
  • Fig 5: Global Neurodiagnostics Market Share (%), By Product, By Value, 2020-2027
  • Fig 6: Global Neurodiagnostics Market Share (%), By Application, By Value, 2020-2027
  • Fig 7: Global Neurodiagnostics Market Share (%), By End User, By Value, 2020-2027
  • Fig 8: Global Neurodiagnostics Market Share (%), By Country, By Value, 2020-2027
  • Fig 9: North America Neurodiagnostics Market Size, By Value (USD Million), 2020-2027
  • Fig 10: North America Neurodiagnostics Market Share (%), By Product, By Value, 2020-2027
  • Fig 11: North America Neurodiagnostics Market Share (%), By Application, By Value, 2020-2027
  • Fig 12: North America Neurodiagnostics Market Share (%), By End User, By Value, 2020-2027
  • Fig 13: North America Neurodiagnostics Market Share (%), By Country, By Value, 2020-2027
  • Fig 14: Europe Neurodiagnostics Market Size, By Value (USD Million), 2020-2027
  • Fig 15: Europe Neurodiagnostics Market Share (%), By Product, By Value, 2020-2027
  • Fig 16: Europe Neurodiagnostics Market Share (%), By Application, By Value, 2020-2027
  • Fig 17: Europe Neurodiagnostics Market Share (%), By End User, By Value, 2020-2027
  • Fig 18: Europe Neurodiagnostics Market Share (%), By Country, By Value, 2020-2027
  • Fig 19: the Asia-Pacific Neurodiagnostics Market Size, By Value (USD Million), 2020-2027
  • Fig 20: the Asia-Pacific Neurodiagnostics Market Share (%), By Product, By Value, 2020-2027
  • Fig 21: the Asia-Pacific Neurodiagnostics Market Share (%), By Application, By Value, 2020-2027
  • Fig 22: the Asia-Pacific Neurodiagnostics Market Share (%), By End User, By Value, 2020-2027
  • Fig 23: the Asia-Pacific Neurodiagnostics Market Share (%), By Country, By Value, 2020-2027
  • Fig 24: Latin America Neurodiagnostics Market Size, By Value (USD Million), 2020-2027
  • Fig 25: Latin America Neurodiagnostics Market Share (%), By Product, By Value, 2020-2027
  • Fig 26: Latin America Neurodiagnostics Market Share (%), By Application, By Value, 2020-2027
  • Fig 27: Latin America Neurodiagnostics Market Share (%), By End User, By Value, 2020-2027
  • Fig 28: Latin America Neurodiagnostics Market Share (%), By Country, By Value, 2020-2027
  • Fig 29: Middle East & Africa Neurodiagnostics Market Size, By Value (USD Million), 2020-2027
  • Fig 30: Middle East & Africa Neurodiagnostics Market Share (%), By Product, By Value, 2020-2027
  • Fig 31: Middle East & Africa Neurodiagnostics Market Share (%), By Application, By Value, 2020-2027
  • Fig 32: Middle East & Africa Neurodiagnostics Market Share (%), By End User, By Value, 2020-2027
  • Fig 33: Middle East & Africa Neurodiagnostics Market Share (%), By Region, By Value, 2020-2027

List of Tables

  • Table 1: Global Neurodiagnostics Market Size, By Product, By Value, 2020-2027
  • Table 2: Global Neurodiagnostics Market Size, By Application, By Value (USD Million), 2020-2027
  • Table 3: Global Neurodiagnostics Market Size, By End User, By Value (USD Million), 2020-2027
  • Table 4: Global Neurodiagnostics Market Size, By Region, By Value (USD Million), 2020-2027
  • Table 5: North America Neurodiagnostics Market Size, By Product, By Value (USD Million), 2020-2027
  • Table 6: North America Neurodiagnostics Market Size, By Application, By Value (USD Million), 2020-2027
  • Table 6: North America Neurodiagnostics Market Size, By End User, By Value (USD Million), 2020-2027
  • Table 7: North America Neurodiagnostics Market Size, By Country, By Value (USD Million), 2020-2027
  • Table 8: Europe Neurodiagnostics Market Size, By Product, By Value (USD Million), 2020-2027
  • Table 9: Europe Neurodiagnostics Market Size, By Application, By Value (USD Million), 2020-2027
  • Table 10: Europe Neurodiagnostics Market Size, By End User, By Value (USD Million), 2020-2027
  • Table 11: Europe Neurodiagnostics Market Size, By Country, By Value (USD Million), 2020-2027
  • Table 12: the Asia-Pacific Neurodiagnostics Market Size, By Product, By Value (USD Million), 2020-2027
  • Table 13: the Asia-Pacific Neurodiagnostics Market Size, By Application, By Value (USD Million), 2020-2027
  • Table 14: the Asia-Pacific Neurodiagnostics Market Size, By End User, By Value (USD Million), 2020-2027
  • Table 15: the Asia-Pacific Neurodiagnostics Market Size, By Country, By Value (USD Million), 2020-2027
  • Table 16: Latin America Neurodiagnostics Market Size, By Product, By Value (USD Million), 2020-2027
  • Table 17: Latin America Neurodiagnostics Market Size, By Application, By Value (USD Million), 2020-2027
  • Table 18: Latin America Neurodiagnostics Market Size, By End User, By Value (USD Million), 2020-2027
  • Table 19: Latin America Neurodiagnostics Market Size, By Country, By Value (USD Million), 2020-2027
  • Table 20: The Middle-East & Africa Neurodiagnostics Market Size, By Product, By Value (USD Million), 2020-2027
  • Table 21: The Middle-East & Africa Neurodiagnostics Market Size, By Application, By Value (USD Million), 2020-2027
  • Table 22: The Middle-East & Africa Neurodiagnostics Market Size, By End User, By Value (USD Million), 2020-2027
  • Table 23: The Middle-East & Africa Neurodiagnostics Market Size, By Country, By Value (USD Million), 2020-2027
  • Table 24: Nihon Kohden Corporation Financial Analysis
  • Table 25: Nihon Kohden Corporation Business Overview
  • Table 26: GE Healthcare Financial Analysis
  • Table 27: GE HealthcareBusiness Overview
  • Table 28: Canon Medical Systems Corporation Financial Analysis
  • Table 29: Canon Medical Systems Corporation Business Overview
  • Table 30: Advanced Brain Monitoring, IncFinancial Analysis
  • Table 31: Advanced Brain Monitoring, IncBusiness Overview
  • Table 32: FUJIFILM Holdings CorporationFinancial Analysis
  • Table 33: FUJIFILM Holdings CorporationBusiness Overview
  • Table 34: Siemens Healthineers Financial Analysis
  • Table 35: Siemens Healthineers Business Overview
  • Table 36: Hoffman-La Roche AG Financial Analysis
  • Table 37: Hoffman-La Roche AG Business Overview
  • Table 38: Lifelines Neuro Company Financial Analysis
  • Table 39: Lifelines Neuro Company Corporation Business Overview
  • Table 40: Bio-Rad LaboratoriesFinancial Analysis
  • Table 41: Bio-Rad LaboratoriesBusiness Overview
  • Table 42: Koninklijke Philips N.V. Financial Analysis
  • Table 43: Koninklijke Philips N.V. Business Overview
  • Table 44: QIAGEN N.V. MedicalFinancial Analysis
  • Table 45: QIAGEN N.V. Medical Financial Analysis
  • Table 46: Natus Medical Incorporated Financial Analysis
  • Table 47: Natus Medical Incorporated Business Overview
  • Table 48: Fujirebio Financial Analysis
  • Table 49:FujirebioBusiness Overview
  • Table 50: Thermo Fisher Scientific, Inc Financial Analysis
  • Table 51: Thermo Fisher Scientific, Inc Business Overview
  • Table 52: Agilent Technologies Financial Analysis
  • Table 53: Agilent Technologies Business Overview
  • Table 54: Hitachi, LtdFinancial Analysis
  • Table 55: Hitachi, Ltd Business Overview
  • Table 56: Ridge Diagnostics Financial Analysis
  • Table 57: Ridge Diagnostics Business Overview
  • Table 58: BrukerFinancial Analysis
  • Table 59: Bruker Business Overview